FLUID TECHNOLOGY GENERATION LIMITED

Financial Health Score: A (Excellent)

Fluid Technology Generation Limited exhibits the financial constitution of a highly robust and vigorous entity. The company displays exceptional liquidity, virtually no long-term debt, and a consistent, multi-year trajectory of strengthening equity. There are no symptoms of financial distress; rather, the patient is in peak financial condition with ample reserves to weather economic illness and fund future growth.

Key Vital Signs

• Pulse Rate (Liquidity & Current Ratio): A robust 4.48:1. The company holds £2.17M in current assets against only £484k in current liabilities. This indicates a tremendously strong, steady financial heartbeat. The business has more than enough liquid resources to meet its short-term obligations without breaking a sweat.
• Blood Pressure (Leverage & Debt): Extremely healthy. Total liabilities stand at £484k against net assets of £1.76M, resulting in a very low debt-to-equity ratio of roughly 0.27. The company is not straining under the weight of excessive borrowing, keeping its financial blood pressure well within the optimal range.
• White Blood Cell Count (Cash Reserves): Highly fortified. Cash at bank has grown from £414k in 2022 to £894,628 in 2026. This represents a strong immune system against unexpected market shocks or trading disruptions.
• Muscle Mass (Retained Earnings Growth): Steady and consistent. The profit and loss reserve has grown from £1.41M in 2022 to £1.75M in 2026. The business is consistently generating and retaining wealth, adding £80k to its reserves in the most recent year alone.
• Bone Density (Tangible Assets): Solid. Net book value of tangible assets increased from £74k to £95k, showing fresh capital expenditure (£52.5k in additions) to maintain the operational "skeleton" of the business, ensuring it doesn't deteriorate.

Diagnosis

The patient is suffering from no discernible financial ailments; in fact, it is in a state of exceptional financial wellness. The underlying business health is characterized by a highly conservative and stable capital structure.

Symptoms Analysis: * Healthy Cash Flow Generation: The consistent upward trajectory of both cash reserves and retained earnings over the last five years indicates a business that is not just generating revenue, but effectively converting it into cash. This is a classic sign of a healthy operational metabolism. * Absence of Long-Term Debt: The balance sheet shows no long-term creditors. The only liabilities are routine trade creditors, other current creditors, and taxation. This means the business is entirely self-funding, requiring no external financial life support. * Related Party Circulation: A notable feature in the bloodwork is the significant transaction volume with its sister company, Safechem Limited. FTG sold £1.18M of goods to Safechem and purchased £165k, with a net receivable of £285k. While currently healthy and noted as transacted at market value, heavy reliance on a related party represents a specific "vascular connection" that requires ongoing monitoring. If Safechem were to fall ill, it could directly impact FTG's working capital.

Recommendations

While the patient is in superb health, preventative care and optimization are key to long-term vitality:

1. Financial Fitness Routine (Cash Optimization): With nearly £900k sitting in the bank, the company may be carrying a little excess "financial fat." While a strong cash reserve is excellent for immunity, excess capital sitting in low-yield accounts can suffer from inflationary muscle wastage. Consider whether a portion of this cash could be deployed into higher-yield investment vehicles, returned to shareholders via dividends, or reinvested into growth initiatives.
2. Monitor the Vascular Connection (Related Party Risk): Given the substantial intercompany trading and the £285k currently owed by Safechem, it is imperative to maintain strict credit control over the related party. Ensure that Safechem's financial health is also regularly assessed so that any signs of distress do not become a contagion risk for FTG.
3. Continue Capital Maintenance (CapEx): The recent investment in plant and machinery is a positive sign. To prevent operational atrophy, continue to invest in equipment and technology to maintain competitive advantage and operational efficiency.
4. Prognosis: The future financial outlook is highly positive. With a fortress balance sheet, no long-term debt, and robust cash generation, this business is well-positioned to navigate economic volatility and self-fund future strategic initiatives. The prognosis is one of sustained financial health and stability.